WooGene B&G Co. Ltd
WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. T… Read more
WooGene B&G Co. Ltd (018620) - Total Liabilities
Latest total liabilities as of September 2025: ₩50.21 Billion KRW
Based on the latest financial reports, WooGene B&G Co. Ltd (018620) has total liabilities worth ₩50.21 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
WooGene B&G Co. Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how WooGene B&G Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
WooGene B&G Co. Ltd Competitors by Total Liabilities
The table below lists competitors of WooGene B&G Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tong-Hwa Synthetic Fiber Co Ltd
TW:1418
|
Taiwan | NT$4.10 Billion |
|
Alien Metals Ltd
PINK:ASLRF
|
USA | $1.71 Million |
|
Oncoinvent ASA
OL:KLDVK
|
USA | Nkr230.30 Million |
|
FarGlory Hotel Co Ltd
TW:2712
|
Taiwan | NT$624.43 Million |
|
C2C Gold Corp
OTCQB:CTCGF
|
USA | $202.85K |
|
Abeo SAS
PA:ABEO
|
France | €231.07 Million |
|
Western Bulk Chartering AS
PINK:WSSTF
|
USA | $57.00 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down WooGene B&G Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how WooGene B&G Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for WooGene B&G Co. Ltd (2011–2024)
The table below shows the annual total liabilities of WooGene B&G Co. Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩85.08 Billion | +72.74% |
| 2023-12-31 | ₩49.25 Billion | -12.37% |
| 2022-12-31 | ₩56.20 Billion | +23.90% |
| 2021-12-31 | ₩45.36 Billion | -4.93% |
| 2020-12-31 | ₩47.72 Billion | -17.54% |
| 2019-12-31 | ₩57.87 Billion | +72.55% |
| 2018-12-31 | ₩33.54 Billion | -10.80% |
| 2017-12-31 | ₩37.60 Billion | +4.42% |
| 2016-12-31 | ₩36.01 Billion | +77.05% |
| 2015-12-31 | ₩20.34 Billion | +142.38% |
| 2014-12-31 | ₩8.39 Billion | +10.11% |
| 2012-12-31 | ₩7.62 Billion | -5.51% |
| 2011-12-31 | ₩8.06 Billion | -- |